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Abstract  
Objective: To evaluate relationship between homocysteine (Hcy), folic acid and vitamin B12 with 
anti-epileptic drugs in epileptic patients and their role in epilepsy control.  
Patient and Methods: The study included 60 patients with idiopathic epilepsy and thirty non-epileptic 
children of the same age and sex served as controls. All cases were subjected to physical and 
neurological examination and electroencephalogram (EEG). Serum level of folic acid, homocysteine 
(Hcy) and vitamin B12 were done for both epileptic patients and controls. Non parametric test, one way 
ANOVA and Pearson’s correlation were used for analysis of data.  
Result: 44 patients (73.3%) had generalized epilepsy and the remaining patients had partial epilepsy 
(simple or complex). 37 patients (61.6%) were in grade I, 3 patients (5 %) were in grade II and the 
remaining 20 patients (33.3 %) were in grade III epilepsy. Vitamin B12 was significantly higher in epileptic 
patients. Duration of anti-epileptic drug treatment was correlated significantly to folic acid and Hcy 
level.  
Conclusion: antiepileptic drugs might upset the homeostatic balance of Hcy and its cofactors and 
cause abnormalities of their serum levels. The duration of anti-epileptic drug treatment was related 
to decrease of folic acid and increase in homocysteine levels. 
 
  
 
 
 
 
Introduction 
Vitamin B12 deficiency has been encountered 
amongst the benign and rare causes of infantile 
seizures. Common symptoms of Vitamin B12 deficiency 
in infants include megaloblastic anemia, feeding 
difficulties, developmental delay, microcephaly, failure to 
thrive, hypotonia, lethargy, irritability, involuntary 
movements, seizures and cerebral atrophy [1].  
The mechanism of the excitatory properties of 
folates is uncertain, but there is some evidence that they 
may do so by blocking or reversing GABA mediated 
inhibition [2].  
Folic acid supplementation was reported to 
reduce epileptic seizure frequency; it has also been 
reported to interfere with the action of anticonvulsant 
medications, resulting in an increase in the frequency 
and/or severity of seizures [3].  
Homocysteine, a sulphur-containing amino acid, 
has been shown to induce seizures in rats [4]. Patients 
on anti-epileptic drugs are prone to high concentrations 
of plasma homocysteine and low status of folate and 
Vitamin B6 [5].  
Increased homocysteine and low folate status 
may contribute to the development of anti-epileptic drug 
related side effects, such as impaired cognitive function 
[6].  
We are aiming to evaluate the relationship 
between the levels of homocysteine and the cofactors 
involved in its metabolism as folic acid and vitamin 
B12 with anti-epileptic drugs in epileptic patients and 
their role in epilepsy control.  
 
Patients and Methods 
It is a cross sectional observational study 
done after obtaining approval from the ethical 
committee of the National Research Centre, Cairo, 
Egypt. Written informed consent was obtained from all 
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patients, their parents and controls after full 
discussion about the aim of the study.  
 
Patients 
The study was conducted on 60 idiopathic 
epilepsy children selected from pediatric neurology 
outpatients’ clinic, Children's Hospital, Ain Shams 
University. 
Children were divided into two groups: Group I, 
comprises 20 newly diagnosed epileptic children not 
receiving anti-epileptic medication (non-AEDs users); 
their mean age was (7 ± 3.16). They were 11 males and 
9 females. Group II, comprises 40 epileptic children on 
regular antiepileptic medication for at least one year 
(AEDs users); their mean age was (10.5 ± 3.16), 
furthermore those were subdivided into: Subgroup A, 
comprises 20 epileptic children receiving monotherapy 
treatment, their mean age was (10.3 ± 3.4). it was 
consisted of 15 patients receiving Valproate (VPA) group 
and the remaining 5 patients were receiving 
carbamazepine (CBZ) group. Subgroup B, included 20 
patients were receiving polytherapy treatment (combined 
treatment with VPA and CBZ). Their mean age was 
(10.6 ± 2.9). Thirty non-epileptic children of the same 
age and sex group served as control group, their mean 
age was (11.0 ± 2.4). 
Table 1: Descriptive statistics of epileptic patients and 
controls. 
Variables Patients Control 
Sex 
Female  30 (50%) 10 (33.3%) 
Male  30 (50%) 20 (66.7%) 
Age 
Mean ± SD 9.3 ± 3.5 11 ± 2.4 
Range (5-15ys) (5-15ys) 
Type of seizures  
Generalized 44 (73.3%) - 
Focal 16 (26.7%) - 
Type of treatment 
Non AEDs 20 (33.33%)  - 
AEDs 40 (66.7%)  - 
Monotherapy (VPA) 15 (25%)  - 
Monotherapy (CBZ) 5 (6.3%)  - 
Polytherapy 20 (33.33%)  - 
AEDs: Anti-epileptic drugs, VPA: Valproate, CBZ : Carbamazepine. 
 
Inclusion criteria of patients 
Children aged from 5 to 15 years old, children 
with idiopathic epilepsy, duration of antiepileptic drug 
treatment not less than one year. 
 
Exclusion criteria of patients 
Children had other diseases affect serum level 
of homocysteine as endocrinal, liver, kidney and cardiac 
diseases, diabetes mellitus and nutritional deficiencies, 
children receiving vitamin supply or folic acid antagonists 
as well as vegetarians. 
All cases were subjected to full history taking , 
underlying etiology (according to the commission on 
Epidemiology and Prognosis, International League 
against Epilepsy, [7] to exclude other causes of epilepsy 
than being idiopathic, type of seizure disorder [according 
to the recommendations of the International League 
against Epilepsy, [8]. Severity of the attack was 
assessed by using Chalfont severity score [9]. 
Complete physical and neurological examination were 
done. Electroencephalogram (EEG): records will be 
classified in EEG abnormalities grades “I, II, III" [10].  
Estimating of serum level of folic acid, 
homocysteine (Hcy), vitamin B12 using 
Chemiluminestence technique were done for both 
epileptic patients and controls. 
Statistical methods 
Statistical Package for social science (SPSS) 
program version 15.0 was used for analysis of data. 
Data was tested for normal distribution using one-
sample Kolomongorov Simirnov test for total sample 
and subgroups, which revealed that data was not 
normally distributed.Non parametric (Mann Whitney 
U) test was used for analysis of two quantitative data 
as data was not symmetrically distributed. One way 
ANOVA was done for analysis of more than two 
quantitative data followed by post HOCC test for 
detection of significance. Pearson’s correlation was 
also done. 
 
Results 
Forty four patients (73.3%) had generalized 
epilepsy and the remaining patients had partial epilepsy 
(simple or complex). 37 patients (61.6%) were in grade I, 
3 patients (5 %) were in grade II and the remaining 20 
patients (33.3 %) were in grade III epilepsy. Table 1 
present the descriptive statistics of patients and controls. 
No significant difference was found between age of 
epileptic patients and controls (9.3 ± 3.5 vs 11.0 ± 2.4 yrs 
respectively). Serum levels of vitamin B12 were 
significantly higher in epileptic patients compared to 
the controls (p=0.03) (Table 2).  
Table 2:  Comparison between mean serum levels of 
homocysteine, folic acid, and vitamin B12 of epileptic patients 
and the controls. 
Variables 
Epileptic 
patients 
Mean ± SD 
N=60 
Controls 
Mean ± SD 
N=30 
P-value 
Homocysteine (µmol/l) 5.9 ± 2.4 5.5 ± 1.4 0.07 
Folic acid (ng/ml) 7.7 ± 3.1 6.4 ± 2.9 0.6 
Vitamin B 12 (pg/ml) 495.7 ± 231.1 443.9 ± 150.3 0.03 
 
 
Comparison between mean serum levels of 
homocysteine, folic acid and vitamin B12 of epileptic 
patients (with different type of treatment) and control 
group (Table 3) and its relation to EEG grades (Table 
4).  
Correlation between serum levels of 
homocysteine, folic acid and vitamin B12 of epileptic 
patients with duration of treatment and Chalfont score 
(Table 5). Correlation between mean serum levels of 
homocysteine, folic acid and vitamin B12 of all 
epileptic patients and those with anti epileptic drugs 
(Table 6).  
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Table 3: Comparison between serum levels of homocysteine, 
folic acid, and vitamin B12 of epileptic patients (with different 
type of treatment) and control group. 
Variables 
Homocysteine 
(µmol/l ) 
Folic acid  
(ng / ml) 
Vitamin B 12  
(pg / ml) 
Non-AEDs users  5.8 ± 1.4 7.3 ± 1.9 433.5 ±171.2 
AEDs users 6.0 ± 2.7 7.9 ± 3.5 526.8 ± 252.1 
Controls 5.5 ± 1.4 6.4 ± 2.9 443.9 ± 150.3 
P-value 0.5 0.1 0.1 
CBZ group  5.5 ± 1.9 6.4 ± 2.7 456.4 ± 252.5 
VPA group  5.4 ± 1.6 8.7 ± 2.6 503.2 ± 321.3 
P-value 0.9 0.09 0.8 
Monotherapy group 5.4 ± 1.6 8.2 ± 2.7 491.5 ± 299.9 
-Polytherapy group 6.7 ± 3.3 7.7 ± 4.2 562.0 ± 194.6 
P-value 0.2 0.7 0.4 
Focal seizures 6.2 ± 1.4 7.8 ± 3.2 533.2 ± 238.2 
Generalized seizures 5.6 ± 2.6 7.7 ± 3.0 482.0 ± 229.7 
P-value 0.1 0.7 0.5 
AEDs: Anti-epileptic drugs, non-AEDs users: non anti-epileptic drugs, VPA: Valproate, 
CBZ : Carbamazepine. 
 
Discussion 
  In the current study, mean serum levels of 
Hcy and folic acid were not significantly higher in all 
epileptic patients and AEDs users compared to 
controls. This is in concordant with Schwaninger et al. 
[11] who observed that patients with normal 
homocysteine plasma concentrations had folate levels 
that were not significantly different from controls [11]. 
Previous studies reported significantly higher serum 
levels of Hcy in epileptic patients when compared to 
controls [12,13]. In contrast to our finding, Aslan et al., 
[13] reported that serum level of folic acid were 
significantly lower in epileptic patients compared to 
controls. 
Table 4: Comparison between mean serum levels of 
homocysteine, folic acid and vitamin B12 of epileptic patients 
in relation to EEG grades. 
Variables 
Grade I 
Mean ± SD 
N = 37 
Grade II 
Mean ± SD 
N = 3 
Grade III 
Mean ± SD 
N = 20 
P -
value 
Homocysteine (µmol/l ) 6.1 ± 2.7 5.4 ± 1.2 5.7 ± 1.7 0.8 
Folic acid (ng / ml) 7.6 ± 3.2 10.6 ± 0.7 7.5 ± 2.9 0.3 
Vitamin B 12 (pg / ml) 478.8 ± 221.5 630.0 ± 360.4 506.7 ± 235.9 0.5 
 
 
Our study showed that mean serum level of 
vitamin B12 was significantly higher in all epileptic 
patients, whereas, its mean serum level was non-
significantly higher in AEDs users when compared to 
controls. This is in agreement with the study done by 
Tamura et al. [14] who found that serum vitamin B12 
concentration were elevated in all patients. On the 
contrary, Karabiber et al. [15] and Aslan et al. [13] 
found low vitamin B12 level in patients; yet, their data 
were not statistically significant. Increased circulating 
vitamin B12 level, however, served as a sensitive 
biochemical index of hepatic damage due to 
anticonvulsants [16]. Prolonged drug treatment was 
possibly the cause of the slightly impaired ability of the 
liver to store vitamin B12 [17].  
Table 5: Correlation between serum levels of homocysteine, 
folic acid and vitamin B12 of epileptic patients in relation to 
duration of treatment and Chalfont score. 
Variables 
Duration of treatment 
(yrs) 
Chalfont score 
r P-value r P-value 
Homocysteine  (µmol/l ) 0.4 0.02 0.2 0.2 
Folic acid  (ng/ml) -0.5 0.03 -0.02 0.9 
Vitamin B 12  (pg/ml) 0.1 0.7 -0.1 0.3 
 
 
Moreover, no difference was observed 
between mean serum levels of Hcy, folic acid and 
vitamin B12 concentration measured in the non-AEDs 
users and the control group. This is in agreement with 
Senera et al. [12], who conducted his study on 75 
patients with idiopathic epilepsy comprised 18 non-
AEDs users and 57 patients receiving anti-epileptic 
drugs, found no significant difference between the two 
groups. 
Table 6: Correlation between mean serum levels of 
homocysteine, folic acid and vitamin B12 of all epileptic 
patients and those with anti epileptic drugs. 
Variables 
Homocysteine 
(µmol/l) 
Folic acid 
(ng/ml) 
Vitamin B 12  
(pg/ml) 
r 
P-
value 
r P-value r 
P-
va-
lue 
All epileptic patients:       
Homocysteine ( µmol/l ) -- -- - 0.6 0.0001 - 0.2 0.2 
Folic acid (ng /ml) - 0.6 0.0001 -- -- 0.1 0.3 
Vitamin B 12 (pg/ml) - 0.2 0.2 0.1 0.3 -- -- 
Patients receiving anti 
epileptic drugs: 
      
Homocysteine (µmol/l ) -- -- -0.5 0.002 0.01 0.9 
Folic acid (ng/ml) -0.5 0.002 -- -- 0.1 0.7 
Vitamin B 12 (pg/ml) 0.01 0.9 0.1 0.7 -- -- 
 
 
 
In the present study, comparing mean serum 
levels of Hcy, folic acid and vitamin B12 in AEDs 
users (66.7%) to non-AEDs users (33.3%), no 
significant difference was found. This is in agreement 
with Cardo et al. [18] and Senera et al. [12] who found 
similar results. Data regarding anti-epileptic drugs and 
their effect on homocysteine metabolism have been 
controversial [12]. It has been reported that 
homocysteine level of patients receiving antiepileptic 
drugs increased by 11.4% to 40% [14, 15, 19]. 
AEDs interfere with folate metabolism in many 
ways, and may potentiate its effect. Folate may serve 
as a cofactor in AEDs catabolism (19). In adults taking 
VPA, folate depletion is normally not observed (20), 
whereas in children receiving VPA, folate depletion 
may develop (21). 
Decreased, normal and increased vitamin B12 
levels have all been reported in patients under long-term 
AEDs administration [14, 15]. It is also worth noting that 
our results showed that mean serum level of Hcy was 
higher but not significant in patients who were 
receiving polytherapy treatment compared to those 
receiving monotherapy treatments. This is in 
concordant with Huemer et al. [19] and Ono et al. [22]. 
Hcy showed no significant difference between 
patients who were receiving CBZ or VPA; this is in 
agreement with the study done by Vurucu et al. [23] 
who found similar results. In the contrary, Gidal et al. 
[24] reported a statistically significant decline in 
plasma Hcy concentration among patients who 
received VPA. 
Our study showed that mean serum folic acid 
level were lower but not significant in patients on 
polytherapy treatment, compared to those on 
monotherapy treatment. This is in concordant with 
Ono et al. [22] and Huemer et al. [19].  
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In the present study, serum folic acid was not 
significantly higher in patients who were receiving 
VPA compared to those who were receiving CBZ. 
This is in agreement with the study done by Geda et 
al. [25] and Gidal et al. [24].  
Various researchers have shown that 
treatment with enzyme-inducing antiepileptic drugs 
(AEDs) including phenytoin, phenobarbital and 
primidone is associated with decreased plasma folate 
concentration in adult and in children [5, 14, 15, 26]. 
These AEDs may interfere with both absorption and 
metabolism of folate [20]. It has also been suggested 
that AED-mediated decrease in plasma folate 
concentration may in part represent a drug–gene 
interaction [22]. 
Also, mean serum level of vitamin B12 
showed no significant difference between patients who 
were receiving polytherapy treatment, and patients on 
monotherapy treatment; the same was found between 
patients who received VPA, or CBZ. This is in 
accordance to the finding of Vurucu et al. [23] who 
conducted a study in 2008 on a total of 93 patients 
with idiopathic epilepsy, 29 were on CBZ and 64 were 
on VPA, and they reported no difference in that mean 
serum level of vitamin B12 in patients who were 
receiving VPA or CBZ. The same was found by Kurul 
et al. [27] who conducted their study on 25 children 
with idiopathic epilepsy (8 on VPA, 11 on CBZ, and 6 
on oxcarbamazepine); they found no difference 
between the mean plasma vitamin B12 levels among 
epileptic patients who received different types of 
antiepileptic drugs.  
In our study there was no significant 
difference between mean serum levels of Hcy, folic 
acid and vitamin B12 with different EEG abnormalities 
(grade I : 61.7% , grade II : 5% , grade III : 33.3%). 
Similarly, Aslan et al. (13) found that there was no 
statistically significant relation between mean serum 
levels of Hcy, folic acid and vitamin B12 with EEG 
abnormalities. 
In the present study, there was no significant 
difference between mean serum level of Hcy, folic 
acid and vitamin B12 and different seizure types. No 
similar study was done studying their level in relation 
to different seizure types. 
Also, we found that duration of therapy 
correlated significantly with elevated serum 
homocysteine (P=0.02) and low serum folic acid 
(P=0.03), which is similar to previous results of 
Schwaninger et al. [11]; Ono et al. [22] and Huemer et 
al. [19]. 
In our study, we found that there was 
significantly negative correlation between Hcy and 
folic acid in the patients using AEDs (p=0.002), and all 
epileptic patients (p=0.0001). This is in accordance to 
the finding of Senera et al. [12] and Aslan et al. [13] 
who found a significant negative correlation between 
the levels of homocysteine and folic acid in patients 
using AEDs and in entire study population. However, 
no association was found between homocysteine and 
vitamin B12. On the contrary, Ono et al. [22] found no 
correlation between Hcy, folic acid and vitamin B12. 
We conclude that, no significant difference 
was found between epileptic patients and controls 
regarding mean serum levels of Hcy and folic acid 
with a significantly higher vitamin B12 levels. Based 
on the previous observations, we can speculate that 
AEDs might upset the homeostatic balance of Hcy 
and its cofactor and cause abnormalities of their 
serum level as evidenced by nonsignificantly higher 
homocysteine and vitamin B12 in patients on 
polytherapy treatment compared to those on 
monotherapy treatment. Also, folic acid level was 
lower but not significant in patients on polytherapy 
treatment compared to those on monotherapy one 
.The duration of anti-epileptic drug treatment was 
correlated significantly to the decrease of folic acid 
and to the increase in homocysteine, yet their serum 
levels didn’t correlate with severity of seizure. 
Although, our study showed that the plasma 
homocysteine level between patients and controls 
were not found significantly different; yet all cases and 
particularly patients on antiepileptic drugs 
demonstrated higher levels of homocysteine. This 
result is compatible with literature findings. As we 
studied both epileptic patients were not receiving 
AEDs (non-AEDs users) and controls, we observed 
that there were no differences in homocysteine levels 
between them, suggesting that, the increase of 
homocysteine levels may be due to anti-epileptic drug 
use, rather than being epileptic in origin. We think that 
we excluded the effect of being epileptic on 
homocysteine status which has not been considered 
in most of the studies. For this reason, we suggest 
that the drugs, rather than the disease, play a major 
role in the development of hyperhomocysteinemia in 
epileptic patients. 
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